MetfoRmin and its Effects on Myocardial Dimension and Left Ventricular Hypertrophy in Normotensive Patients with Coronary Artery Disease (MET-REMODEL Trial)
Mohan, M., McSwiggan, S., Baig, F., Rutherford, L. & Lang, C. C. (Lead / Corresponding author), 1 Feb 2015, In: Cardiovascular Therapeutics.33, 1, p. 1-88 p.
Research output: Contribution to journal › Review article › peer-review